The impact of COVID-19 in a cohort of patients with systemic sclerosis
Description
CONCLUSIONS: COVID-19 disease in patients with SSc can be overcome in most cases, even when they are ILD and were using immunosuppressants at the time of infection with the SARS-CoV-2 virus.
